Silvia Davila
Known title: DirectorCIK: 0002005074
Associated companies
Transaction History
| FDX | ▲ Buy | Grant | 823 | $0 | 9/29/2025 | View on chart |
| FDX | ▲ Buy | Grant | 295 | $70K | 9/29/2025 | View on chart |
| FDX | ▲ Buy | Grant | 755 | $0 | 9/23/2024 | View on chart |
| FDX | ▲ Buy | Grant | 271 | $70K | 9/23/2024 | View on chart |
| FDX | ▲ Buy | Grant | 212 | $52K | 12/22/2023 | View on chart |
| FDX | ▲ Buy | Grant | 591 | $0 | 12/22/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking
FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking. FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.